☰

Jennifer Shoemaker, Ph.D.

Affiliations: 
2007 University of Arkansas for Medical Sciences, United States 
Area:
Pharmacology, Neuroscience Biology
Google:
"Jennifer Shoemaker"
Mean distance: 30533.1
 
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor
Paul L. Prather grad student 2007 UAMS
 (Targeting cannabinoid CB2 receptors as potential therapeutic agents for the treatment of Amyotrophic Lateral Sclerosis.)

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Shoemaker JL, Seely KA, Reed RL, et al. (2007) The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset. Journal of Neurochemistry. 101: 87-98
Shoemaker JL, Ruckle MB, Mayeux PR, et al. (2005) Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors. The Journal of Pharmacology and Experimental Therapeutics. 315: 828-38
Shoemaker JL, Joseph BK, Ruckle MB, et al. (2005) The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors. The Journal of Pharmacology and Experimental Therapeutics. 314: 868-75
See more...